The prevalence of inherited neuromuscular disease in Northern Ireland

Neuromuscular Disorders

Volumn 6, Issue 1, 1996, Pages 69-73

  Hughes, M I ^b   Hicks, E M ^b   Nevin, N C ^b   Patterson, V H ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Epidemiology; Hereditary neuropathy; Muscular dystrophy; Myopathy; Prevalence

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULAR DYSTROPHY; MYOPATHY; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 0030042419     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-8966(94)00017-4     Document Type: Article

References (21)

1. Emery A E H. Population frequencies of inherited neuromuscular diseases - a world survey. Neuromusc Disord 1991; 1: 19-29.
2. Stevenson A C. Muscular dystrophy in Northern Ireland. Ann Eugen (London) 1953; 18: 50-93.
3. Lynas M A. Dystrophia myotonia with special reference to Northern Ireland. Ann Hum Genet. 1957; 21: 318-351.
4. Department of Health and Social Services Registrar General Northern Ireland. The Northern Ireland Census 1991. Belfast HMSO.
5. World Federation of Neurology Research Committee Research Group on Neuromuscular Diseases. Classification of Neuromuscular Diseases. J Neurol Sci 1988; 86: 333-360.
6. Emery A E H. (Ed) Diagnostic criteria for neuromuscular disorders. European Neuromuscular Centre, Baarn, The Netherlands, 1994.
7. Mathieu J, De Braekeleer M, Prevost C. Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology 1990; 40: 839-842.
8. Monckton G, Hoskin V, Warren S. Prevalence and incidence of muscular dystrophy in Alberta, Canada. Clin Genet 1982; 21: 19-24.
9. Grimm T. The age of onset and the age of death in patients with dystrophica myotonica. J Genet Hum 1957; 21: 318-351.
10. Klein D. Myotonic dystrophy (Steinart) and myotonia congenita (Thomsen) in Switzerland (in French). J Genet Hum (Suppl.) 1958; 7: 1-328.
11. Gumundsson K R. The prevalence of some neurological diseases in Iceland. Acta Neurol Scand 1968; 44: 57-69.
12. Prot J. Genetic-epidemiological studies in progressive muscular dystrophy. J Med Genet 1971; 8: 90-96.
13. Araki S, Uchino M. Kumamoto T. Prevalance studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto District, Japan. Gen Epidemiol 1987; 6: 120-129.
14. Lucci B. Incidence, prevalence and mutation rate of Duchenne muscular dystrophy in the province of Reggio Emilia. In: Angelini C, Danielo G A, Fontanari D eds. Muscular Dystrophy Research: Advances and New Trends. Amsterdam: Excerpta Medica, 1980: 289-290.
15. Mostacciuolo M L, Lombardi A, Cambissa V, Danieli G A, Angelini C. Population data on benign and severe forms of X-linked muscular dystrophy. Hum Genet 1987; 75: 217-220.
16. Nakagawa M, Nakahara K, Yoshidome H et al. Epidemiology of progressive muscular dystrophy in Okinawa, Japan. Neuroepidemiology 1991; 10: 185-191.
17. Bushby K M D, Thambyayah M, Gardner-Medwin D. Prevalence and incidence of Becker muscular dystrophy. Lancet 1991; 337: 1022-1024.
18. Lunt P. Fascioscapulohumeral muscular dystrophy. MD Thesis 1990.
19. Pearn J. Incidence, prevalence and gene frequency studies of chronic childhood spinal muscular atrophy. J. Med Genet 1978; 15: 409-413.
20. Becker P E. Myotonia Congenita and Syndromes Associated with Myotonia. Stuttgart: Georg Thieme, 1977.
21. Becker P E. Paramyotonia Congenita (Eulenberg). Stuttgart: Georg Thieme, 1970.